CNS Pharmaceuticals, Inc.CC

CNS Pharmaceuticals, Inc.

3.81USDR
+0.26+7.32%
Last update at 23:45 GMT
3.80USD
−0.01−0.26%
No tradesPost-marketLast update at 22:46 GMT
See on Supercharts
Back

Operating expenses (excl. COGS) of CNS Pharmaceuticals, Inc.

Annual data
2018
2019
2020
2021
2022
2023
TTM
‪‪−20.00 M‬‬
‪‪−15.00 M‬‬
‪‪−10.00 M‬‬
‪‪−5.00 M‬‬
‪0.00‬
Period
Value
Change
Change %
TTM
‪‪−17.08 M‬‬
+‪‪1.78 M‬‬
+‪9.45‬%
2023
‪‪−18.86 M‬‬
‪‪−3.94 M‬‬
‪−26.40‬%
2022
‪‪−14.92 M‬‬
‪‪−448.37 K‬‬
‪−3.10‬%
2021
‪‪−14.47 M‬‬
‪‪−5.03 M‬‬
‪−53.26‬%
2020
‪‪−9.44 M‬‬
‪‪−5.61 M‬‬
‪−146.50‬%
2019
‪‪−3.83 M‬‬
‪‪−2.95 M‬‬
‪−334.46‬%
2018
Quarterly data
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−6.00 M‬‬
‪‪−4.50 M‬‬
‪‪−3.00 M‬‬
‪‪−1.50 M‬‬
‪0.00‬
Period
Value
Change
Change %
Q3 '24
‪‪−5.63 M‬‬
‪‪−3.10 M‬‬
‪−122.69‬%
Q2 '24
‪‪−2.53 M‬‬
+‪‪1.02 M‬‬
+‪28.69‬%
Q1 '24
‪‪−3.54 M‬‬
+‪‪1.83 M‬‬
+‪34.11‬%
Q4 '23
‪‪−5.38 M‬‬
‪‪−845.48 K‬‬
‪−18.65‬%
Q3 '23
‪‪−4.53 M‬‬
‪‪−508.56 K‬‬
‪−12.64‬%
Q2 '23
‪‪−4.02 M‬‬
+‪‪900.85 K‬‬
+‪18.29‬%
Q1 '23
‪‪−4.93 M‬‬
+‪‪240.23 K‬‬
+‪4.65‬%
Q4 '22
‪‪−5.17 M‬‬
‪‪−1.75 M‬‬
‪−51.20‬%
Q3 '22
Q2 '22
Q1 '22
Q4 '21
Q3 '21
Q2 '21
Q1 '21
Q4 '20
Q3 '20
Q2 '20
Q1 '20
Q4 '19
Q3 '19
Q2 '19
Q1 '19
Q4 '18
Q3 '18
Q2 '18